INNOVATION AT DEVICETALKS BOSTON
Osso VR co-founder and CEO Justin Barad thinks there’s a medtech innovation bottleneck when it comes to ensuring health providers are using new technology to produce better results. “How do we get more people to use these technologies, and how do we get them to do it more correctly?”
Boston Scientific SVP and President of Urology Meghan Scanlon [Photo courtesy of Boston Scientific]
Sagentia Innovation Medical Managing Partner Duncan Smith spoke on the potential for medtech innovation to contribute to a sustainable future. “Just by good, solid system engineering, you can have a radical impact on sustainability.” As a first step, “you have to choose a goal that’s meaningful for your organization.”
Dr. Nitin Goyal is Zimmer Biomet’s chief science, technology and innovation officer. [Photo courtesy of Zimmer Biomet]
FundamentalVR co-founder and CEO Richard Vincent spoke on the benefits of their virtual reality (VR) solution for surgical training. “We’ve seen that VR has been proven to accelerate learning, and haptic VR has been proven to accelerate skill transfer and acquisition.” VR can achieve significant logistic time and cost savings, he said: “It allows us to continue to provide opportunities to learn.”
While pulsed-field ablation is a trending topic in medtech, treating atrial fibrillation (AFib) with gold-standard methods can be a long process. Boston Scientific Chair and CEO Mike Mahoney thinks AFib treatment could become a 45-minute outpatient procedure within a few years because of continued innovation in interventional surgery. “The interventional space is a great benefit in the long term for any company,” he said. “We try to disrupt surgery.”
